HomeNews

News

COVID-19 UPDATE: Current Offerings/How can we help your lab?

Impacted by COVID-19? We are here for you and ready to help We have received reports from some of our customers that the closures at their institutions due to the COVID–19 pandemic are causing disruptions in their work. While it is not completely “business as usual” for our company, we have resources in place to provide you …

COVID-19 UPDATE: Current Offerings/How can we help your lab? Read More »

Continuity of business in response to COVID-19

As the situation regarding the COVID-19 outbreak changes daily, we wanted to advise you on how we are addressing the issue at InVivo Biosystems. Our top priorities are the health and safety of our employees and ensuring that our customer’s project can continue uninterrupted. This effort starts with our internal readiness efforts. Internal teams have …

Continuity of business in response to COVID-19 Read More »

NemaMetrix raises $5 million USD funding and strengthens senior team

  Investment will be used to further develop the Company’s Precisome platform for functional analysis New investment led by Oregon Venture Fund Dr Stephen Turner appointed as Senior Research Fellow to help lead company expansion   Eugene, Oregon, USA, 29 July 2019: NemaMetrix, an Oregon-based company that provides phenotyping and functional analysis using C. elegans …

NemaMetrix raises $5 million USD funding and strengthens senior team Read More »

New Milestone! We can now remove over 36,000 bp from C. elegans genomic DNA!

12,000, 24,000…we can now precisely remove over 36,000 bp from C. elegans genomic DNA! Knocking out genes is a commonly used tool for biologists to understand gene function in live animals. The examination of phenotypes when a gene is deleted can reveal valuable insights into what role that gene plays in the organism and by …

New Milestone! We can now remove over 36,000 bp from C. elegans genomic DNA! Read More »

Scroll to Top